Anthelmintic Drugs Market Analysis from 2022 to 2034 Containing Market Size, Share along with its CAGR, Forecast and Trends

Top Countries — Revenue

USD Million/Billion
Loading…

Access the full forecast model.

Country-level data · Company profiles · Editable dataset · Analyst consultation included.

Anthelmintic Drugs Market Analysis — Presence

Interactive World Map

Click countries to explore
Loading map…

Regional and Country Analysis

  • North America — United States, Canada, Mexico
  • Europe — United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Switzerland, Luxembourg, Rest of Europe
  • Asia Pacific — China, Japan, South Korea, India, Australia, Singapore, Taiwan, South East Asia, Rest of APAC
  • South America — Brazil, Argentina, Colombia, Peru, Chile, Rest of South America
  • Middle East — Saudi Arabia, Turkey, UAE, Egypt, Qatar, Rest of Middle East
  • Africa — East Africa, West Africa, North Africa, South Africa

Region / Country 2021 (A)2025 (A)2033 (P) CAGR

A = Actual · E = Estimated · P = Projected · 🔒 Locked values require full access. Click headers to sort.

Unlock full regional dataset →

Segmentation Analysis

Market size by (Illustrative, 2025)
Share distribution (2025)

Charts are illustrative — exact values, country-level breakdowns, and full forecast in the paid report. Request a Free Sample PDF.

To learn more about market share and segmentation, request the free sample pages.

Competitive Landscape of the Anthelmintic Drugs Market

The major players adopt inventive strategies quickly to gain an edge over their rivals and take a major market share. To serve a sizable customer base and obtain a competitive advantage, major players in the Anthelmintic Drugs market place an enormous value on extending their unique offers.

Anthelmintic Drugs Industry News

  • February 2021, Merck said that the FDA had approved KOMBITRIM, their newest oral combination medication, to treat certain worm-caused parasitic diseases in both adults and children. Ivermectin and albendazole, two popular anthelmintic drugs, are combined in a pill called KOMBITRIM.

(Source: www.merck.com/news/merck-statement-on-ivermectin-use-during-the-covid-19-pandemic/)

Click any bar or cell to request the full company profile
Company2022 (A)2023 (A)2024 (A)2025 (A)
GlaxoSmithKline plc ••• ••• ••• •••
Johnson & Johnson ••• ••• ••• •••
Merck & Co. Inc. ••• ••• ••• •••
Bayer AG ••• ••• ••• •••
Cipla Ltd. ••• ••• ••• •••
Sun Pharmaceutical Industries Ltd. ••• ••• ••• •••
Teva Pharmaceutical Industries Limited ••• ••• ••• •••
Reese Pharmaceutical Company ••• ••• ••• •••
Zydus Lifesciences Limited••• ••• ••• •••

Revenue data requires full access. *2nd & 3rd tier companies available on enquiry.

Request company profile for validation →

Report Scope & Analysis

According to Cognitive Market Research, The Global Anthelmintic Drugs market size is USD 1121.5 million in 2023 and will expand at a compound annual growth rate (CAGR) of 4.30% from 2023 to 2030.

  • North America Anthelmintic Drugs held the major market of more than 40% of the global revenue with a market size of USD 448.60 million in 2023 and will grow at a compound annual growth rate (CAGR) of 2.5% from 2023 to 2030.
  • Europe Anthelmintic Drugs accounted for a share of over 30% of the global market size of USD 336.45 million in 2023.
  • Asia Pacific Anthelmintic Drugs held the market of more than 23% of the global revenue with a market size of USD 257.95 million in 2023 and will grow at a compound annual growth rate (CAGR) of 6.3% from 2023 to 2030.
  • South America Anthelmintic Drugs market of more than 5% of the global revenue with a market size of USD 56.08 million in 2023 and will grow at a compound annual growth rate (CAGR) of 3.7% from 2023 to 2030.
  • Middle East and Africa Anthelmintic Drugs held the major market of more than 2% of the global revenue with a market size of USD 22.43 million in 2023 and will grow at a compound annual growth rate (CAGR) of 4.0% from 2023 to 2030.
  • Development of new drugs and drug combinations, there is an increasing need for Anthelmintic Drugs.
  • The market for Anthelmintic Drugs continues to be more in demand from Benzimidazoles.
  • In 2023, the category with the largest revenue share in the Anthelmintic Drugs market was Hospital Pharmacies.

Introduction of the Anthelmintic Drugs Market

Pharmaceuticals intended to treat infections brought on by helminth infections are included in the market for anthelmintic drugs. These medications are essential in veterinary and human medicine to treat worm infestations, including roundworms, tapeworms, and flukes. Anthelmintic drugs interfere with the nervous system or metabolism of helminths, killing the parasites or stopping their growth. The market covers various applications, including companion animal and livestock care and human healthcare. The need for anthelmintic medications is driven by the prevalence of helminth infections, especially in areas with inadequate sanitation and high animal density. In the market for anthelmintic drugs, ongoing research and technical developments have led to the development of increasingly potent and focused treatments.

Analyst Conclusion

Author's Say's

  • Between 2023 and 2030, the market for Anthelmintic Drugs will grow at a 4.30% CAGR, which is a substantial growth rate.
  • Development of new drugs and drug combinations, there is an increasing need for Anthelmintic Drugs.
  • In 2023, the category with the largest revenue share in the Anthelmintic Drugs market was Hospital Pharmacies.
  • Up to 2030, the market for Anthelmintic Drugs in Europe will develop at the fastest rate, while North America will continue to lead in this area

Supriya Yadav
Supriya Yadav Verified Analyst
Research Analyst · Cognitive Market Research
LinkedIn Profile Book Appointment

Frequently Asked Questions

The global market size for Anthelmintic Drugs in 2023 was 1121.5 USD million.
The global Anthelmintic Drugs market is expected to grow with a CAGR of 4.30% over the projected period.
North America held a significant global Anthelmintic Drugs market revenue share in 2023.
Europe will witness the fastest growth of the global Anthelmintic Drugs market over the coming years.
The US had the most significant global Anthelmintic Drugs market revenue share in 2023.
The main drivers of the growth of the Anthelmintic Drugs market are Development of new drugs and drug combinations, expansion of veterinary care and rising incidence of parasitic worm infections.
The oral segment had the largest share in the global Anthelmintic Drugs market by Route of Administration.
In 2023, the Benzimidazoles had a significant revenue share in the global Anthelmintic Drugs market in terms of drug class.

★ Reviews

Rate this report

Anthelmintic Drugs Market Analysis — Table of Contents

Disclaimer: Redacted sample for representative purposes. Charts and data do not depict actual statistics. TOC varies by license selection.
License Edition

Drug Class Benzimidazoles, Piperazine, Others
Application Human, Animal
Route of Administration Oral, Injectable
Distribution Channel Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Veterinary Pharmacies, Veterinary Hospitals & Clinics
List of Competitors GlaxoSmithKline plc , Johnson & Johnson , Merck & Co. Inc. , Bayer AG , Cipla Ltd. , Sun Pharmaceutical Industries Ltd. , Teva Pharmaceutical Industries Limited , Reese Pharmaceutical Company , Zydus Lifesciences Limited

  • 1.1 Global Power Realignment & Strategic Alliances
  • 1.2 Geopolitical Risk Landscape & Conflict Hotspots
  • 1.3 International Trade Relations & Market Access Environment
  • 1.4 Regulatory & Policy Shifts Impacting Cross-Border Operations
  • 1.5 Supply Chain Resilience, Localization & Resource Nationalism
  • 1.6 Technology Sovereignty & Digital Geopolitics
  • 1.7 Strategic Implications for Investment, Growth & Market Entry

  • 2.1 Competitive Landscape Disruption & Strategic Shifts
  • 2.2 AI-Driven Transformation of Industry Value Chain
  • 2.3 Evolution of Business Models & Revenue Streams
  • 2.4 Operational Efficiency & Cost Structure Transformation
  • 2.5 Product, Service & Innovation Acceleration
  • 2.6 Customer Behavior & Demand Evolution
  • 2.7 Future Outlook: AI-Led Market Evolution & Strategic Implications

  • 3.1 Global Anthelmintic Drugs Revenue Market Size, Trend Analysis 2022 - 2034
  • 3.2 Global Anthelmintic Drugs Volume Market Sales, Trend Analysis 2022 - 2034

  • Global Market has been segmented on the basis 5 major regions such as North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America.

    3.3 Global Anthelmintic Drugs Market Size By Regions 2022 - 2034
    • 3.3.1 Global Anthelmintic Drugs Revenue Market Size By Region
    • 3.3.2 Global Anthelmintic Drugs Volume Market Sales By Region
  • 3.4 Global Anthelmintic Drugs Market Size By Drug Class 2022 - 2034
    • 3.4.1 Benzimidazoles Market Size
    • 3.4.2 Piperazine Market Size
    • 3.4.3 Others Market Size
  • 3.5 Global Anthelmintic Drugs Volume Market Sales By Drug Class 2022 - 2034
    • 3.5.1 Benzimidazoles Sales Volume
    • 3.5.2 Piperazine Sales Volume
    • 3.5.3 Others Sales Volume
  • 3.6 Global Anthelmintic Drugs Market Size By Application 2022 - 2034
    • 3.6.1 Human Market Size
    • 3.6.2 Animal Market Size
  • 3.7 Global Anthelmintic Drugs Volume Market Sales By Application 2022 - 2034
    • 3.7.1 Human Sales Volume
    • 3.7.2 Animal Sales Volume
  • 3.8 Global Anthelmintic Drugs Market Size By Route of Administration 2022 - 2034
    • 3.8.1 Oral Market Size
    • 3.8.2 Injectable Market Size
  • 3.9 Global Anthelmintic Drugs Volume Market Sales By Route of Administration 2022 - 2034
    • 3.9.1 Oral Sales Volume
    • 3.9.2 Injectable Sales Volume
  • 3.10 Global Anthelmintic Drugs Market Size By Distribution Channel for 2022 - 2034
    • 3.10.1 Hospital Pharmacies Market Size
    • 3.10.2 Retail Pharmacies Market Size
    • 3.10.3 Online Pharmacies Market Size
    • 3.10.4 Veterinary Pharmacies Market Size
    • 3.10.5 Veterinary Hospitals & Clinics Market Size
  • 3.11 Global Anthelmintic Drugs Volume Market Sales By Distribution Channel 2022 - 2034
    • 3.11.1 Hospital Pharmacies Sales Volume
    • 3.11.2 Retail Pharmacies Sales Volume
    • 3.11.3 Online Pharmacies Sales Volume
    • 3.11.4 Veterinary Pharmacies Sales Volume
    • 3.11.5 Veterinary Hospitals & Clinics Sales Volume
  • 3.12 Global Level Competitor Analysis (Subject to Data Availability (Private Players))

  • You can purchase only the Executive Summary of Global Market (2019 vs 2024 vs 2031)

    3.13 Executive Summary Global Market (2021 vs 2025 vs 2033)
    • 3.13.1 Regional Market Revenue Summary 2021 vs 2025 vs 2033
    • 3.13.2 Regional Volume Market Summary 2021 vs 2025 vs 2033
    • 3.13.3 Global Market Revenue Split By Drug Class
    • 3.13.4 Global Volume Market Split By Drug Class
    • 3.13.5 Global Market Revenue Split By Application
    • 3.13.6 Global Volume Market Split By Application
    • 3.13.7 Global Market Revenue Split By Route of Administration
    • 3.13.8 Global Volume Market Split By Route of Administration
    • 3.13.9 Global Market Revenue Split By Distribution Channel
    • 3.13.10 Global Volume Market Split By Distribution Channel

    • Global Market Dynamics, Trends, Drivers, Restraints, Opportunities, Only Pointers will be deliverable

      3.13.11 Global Market Dynamics, Trends, Drivers, Restraints, Opportunities

  • 4.1 North America Anthelmintic Drugs Market Outlook
    • 4.1.1 North America Anthelmintic Drugs Market Size 2022 - 2034
    • 4.1.2 North America Anthelmintic Drugs Volume Market Sales 2022 - 2034
    • 4.1.3 North America Anthelmintic Drugs Market Size By Country 2022 - 2034
    • 4.1.4 North America Anthelmintic Drugs Volume Market Sales By Country 2022 - 2034
    • 4.1.5 North America Anthelmintic Drugs Market Size by Drug Class 2022 - 2034
      • 4.1.5.1 North America Benzimidazoles Market Size
      • 4.1.5.2 North America Piperazine Market Size
      • 4.1.5.3 North America Others Market Size
    • 4.1.6 North America Anthelmintic Drugs Volume Market Sales by Drug Class 2022 - 2034
      • 4.1.6.1 North America Benzimidazoles Sales Volume
      • 4.1.6.2 North America Piperazine Sales Volume
      • 4.1.6.3 North America Others Sales Volume
    • 4.1.7 North America Anthelmintic Drugs Market Size by Application 2022 - 2034
      • 4.1.7.1 North America Human Market Size
      • 4.1.7.2 North America Animal Market Size
    • 4.1.8 North America Anthelmintic Drugs Volume Market Sales by Application 2022 - 2034
      • 4.1.8.1 North America Human Sales Volume
      • 4.1.8.2 North America Animal Sales Volume
    • 4.1.9 North America Anthelmintic Drugs Market Size by Route of Administration 2022 - 2034
      • 4.1.9.1 North America Oral Market Size
      • 4.1.9.2 North America Injectable Market Size
    • 4.1.10 North America Anthelmintic Drugs Volume Market Sales by Route of Administration 2022 - 2034
      • 4.1.10.1 North America Oral Sales Volume
      • 4.1.10.2 North America Injectable Sales Volume
    • 4.1.11 North America Anthelmintic Drugs Market Size by Distribution Channel 2022 - 2034
      • 4.1.11.1 North America Hospital Pharmacies Market Size
      • 4.1.11.2 North America Retail Pharmacies Market Size
      • 4.1.11.3 North America Online Pharmacies Market Size
      • 4.1.11.4 North America Veterinary Pharmacies Market Size
      • 4.1.11.5 North America Veterinary Hospitals & Clinics Market Size
    • 4.1.12 North America Anthelmintic Drugs Volume Market Sales by Distribution Channel 2022 - 2034
      • 4.1.12.1 North America Hospital Pharmacies Sales Volume
      • 4.1.12.2 North America Retail Pharmacies Sales Volume
      • 4.1.12.3 North America Online Pharmacies Sales Volume
      • 4.1.12.4 North America Veterinary Pharmacies Sales Volume
      • 4.1.12.5 North America Veterinary Hospitals & Clinics Sales Volume

  • 5.1 Europe Anthelmintic Drugs Market Outlook
    • 5.1.1 Europe Anthelmintic Drugs Market Size 2022 - 2034
    • 5.1.2 Europe Anthelmintic Drugs Volume Market Sales 2022 - 2034
    • 5.1.3 Europe Anthelmintic Drugs Market Size By Country 2022 - 2034
    • 5.1.4 Europe Anthelmintic Drugs Volume Market Sales By Country 2022 - 2034
    • 5.1.5 Europe Anthelmintic Drugs Market Size by Drug Class 2022 - 2034
      • 5.1.5.1 Europe Benzimidazoles Market Size
      • 5.1.5.2 Europe Piperazine Market Size
      • 5.1.5.3 Europe Others Market Size
    • 5.1.6 Europe Anthelmintic Drugs Volume Market Sales by Drug Class 2022 - 2034
      • 5.1.6.1 Europe Benzimidazoles Sales Volume
      • 5.1.6.2 Europe Piperazine Sales Volume
      • 5.1.6.3 Europe Others Sales Volume
    • 5.1.7 Europe Anthelmintic Drugs Market Size by Application 2022 - 2034
      • 5.1.7.1 Europe Human Market Size
      • 5.1.7.2 Europe Animal Market Size
    • 5.1.8 Europe Anthelmintic Drugs Volume Market Sales by Application 2022 - 2034
      • 5.1.8.1 Europe Human Sales Volume
      • 5.1.8.2 Europe Animal Sales Volume
    • 5.1.9 Europe Anthelmintic Drugs Market Size by Route of Administration 2022 - 2034
      • 5.1.9.1 Europe Oral Market Size
      • 5.1.9.2 Europe Injectable Market Size
    • 5.1.10 Europe Anthelmintic Drugs Volume Market Sales by Route of Administration 2022 - 2034
      • 5.1.10.1 Europe Oral Sales Volume
      • 5.1.10.2 Europe Injectable Sales Volume
    • 5.1.11 Europe Anthelmintic Drugs Market Size by Distribution Channel 2022 - 2034
      • 5.1.11.1 Europe Hospital Pharmacies Market Size
      • 5.1.11.2 Europe Retail Pharmacies Market Size
      • 5.1.11.3 Europe Online Pharmacies Market Size
      • 5.1.11.4 Europe Veterinary Pharmacies Market Size
      • 5.1.11.5 Europe Veterinary Hospitals & Clinics Market Size
    • 5.1.12 Europe Anthelmintic Drugs Volume Market Sales by Distribution Channel 2022 - 2034
      • 5.1.12.1 Europe Hospital Pharmacies Sales Volume
      • 5.1.12.2 Europe Retail Pharmacies Sales Volume
      • 5.1.12.3 Europe Online Pharmacies Sales Volume
      • 5.1.12.4 Europe Veterinary Pharmacies Sales Volume
      • 5.1.12.5 Europe Veterinary Hospitals & Clinics Sales Volume

  • 6.1 Asia Pacific Anthelmintic Drugs Market Outlook
    • 6.1.1 Asia Pacific Anthelmintic Drugs Market Size 2022 - 2034
    • 6.1.2 Asia Pacific Anthelmintic Drugs Volume Market Sales 2022 - 2034
    • 6.1.3 Asia Pacific Anthelmintic Drugs Market Size By Country 2022 - 2034
    • 6.1.4 Asia Pacific Anthelmintic Drugs Volume Market Sales By Country 2022 - 2034
    • 6.1.5 Asia Pacific Anthelmintic Drugs Market Size by Drug Class 2022 - 2034
      • 6.1.5.1 Asia Pacific Benzimidazoles Market Size
      • 6.1.5.2 Asia Pacific Piperazine Market Size
      • 6.1.5.3 Asia Pacific Others Market Size
    • 6.1.6 Asia Pacific Anthelmintic Drugs Volume Market Sales by Drug Class 2022 - 2034
      • 6.1.6.1 Asia Pacific Benzimidazoles Sales Volume
      • 6.1.6.2 Asia Pacific Piperazine Sales Volume
      • 6.1.6.3 Asia Pacific Others Sales Volume
    • 6.1.7 Asia Pacific Anthelmintic Drugs Market Size by Application 2022 - 2034
      • 6.1.7.1 Asia Pacific Human Market Size
      • 6.1.7.2 Asia Pacific Animal Market Size
    • 6.1.8 Asia Pacific Anthelmintic Drugs Volume Market Sales by Application 2022 - 2034
      • 6.1.8.1 Asia Pacific Human Sales Volume
      • 6.1.8.2 Asia Pacific Animal Sales Volume
    • 6.1.9 Asia Pacific Anthelmintic Drugs Market Size by Route of Administration 2022 - 2034
      • 6.1.9.1 Asia Pacific Oral Market Size
      • 6.1.9.2 Asia Pacific Injectable Market Size
    • 6.1.10 Asia Pacific Anthelmintic Drugs Volume Market Sales by Route of Administration 2022 - 2034
      • 6.1.10.1 Asia Pacific Oral Sales Volume
      • 6.1.10.2 Asia Pacific Injectable Sales Volume
    • 6.1.11 Asia Pacific Anthelmintic Drugs Market Size by Distribution Channel 2022 - 2034
      • 6.1.11.1 Asia Pacific Hospital Pharmacies Market Size
      • 6.1.11.2 Asia Pacific Retail Pharmacies Market Size
      • 6.1.11.3 Asia Pacific Online Pharmacies Market Size
      • 6.1.11.4 Asia Pacific Veterinary Pharmacies Market Size
      • 6.1.11.5 Asia Pacific Veterinary Hospitals & Clinics Market Size
    • 6.1.12 Asia Pacific Anthelmintic Drugs Volume Market Sales by Distribution Channel 2022 - 2034
      • 6.1.12.1 Asia Pacific Hospital Pharmacies Sales Volume
      • 6.1.12.2 Asia Pacific Retail Pharmacies Sales Volume
      • 6.1.12.3 Asia Pacific Online Pharmacies Sales Volume
      • 6.1.12.4 Asia Pacific Veterinary Pharmacies Sales Volume
      • 6.1.12.5 Asia Pacific Veterinary Hospitals & Clinics Sales Volume

  • 7.1 South America Anthelmintic Drugs Market Outlook
    • 7.1.1 South America Anthelmintic Drugs Market Size 2022 - 2034
    • 7.1.2 South America Anthelmintic Drugs Volume Market Sales 2022 - 2034
    • 7.1.3 South America Anthelmintic Drugs Market Size By Country 2022 - 2034
    • 7.1.4 South America Anthelmintic Drugs Volume Market Sales By Country 2022 - 2034
    • 7.1.5 South America Anthelmintic Drugs Market Size by Drug Class 2022 - 2034
      • 7.1.5.1 South America Benzimidazoles Market Size
      • 7.1.5.2 South America Piperazine Market Size
      • 7.1.5.3 South America Others Market Size
    • 7.1.6 South America Anthelmintic Drugs Volume Market Sales by Drug Class 2022 - 2034
      • 7.1.6.1 South America Benzimidazoles Sales Volume
      • 7.1.6.2 South America Piperazine Sales Volume
      • 7.1.6.3 South America Others Sales Volume
    • 7.1.7 South America Anthelmintic Drugs Market Size by Application 2022 - 2034
      • 7.1.7.1 South America Human Market Size
      • 7.1.7.2 South America Animal Market Size
    • 7.1.8 South America Anthelmintic Drugs Volume Market Sales by Application 2022 - 2034
      • 7.1.8.1 South America Human Sales Volume
      • 7.1.8.2 South America Animal Sales Volume
    • 7.1.9 South America Anthelmintic Drugs Market Size by Route of Administration 2022 - 2034
      • 7.1.9.1 South America Oral Market Size
      • 7.1.9.2 South America Injectable Market Size
    • 7.1.10 South America Anthelmintic Drugs Volume Market Sales by Route of Administration 2022 - 2034
      • 7.1.10.1 South America Oral Sales Volume
      • 7.1.10.2 South America Injectable Sales Volume
    • 7.1.11 South America Anthelmintic Drugs Market Size by Distribution Channel 2022 - 2034
      • 7.1.11.1 South America Hospital Pharmacies Market Size
      • 7.1.11.2 South America Retail Pharmacies Market Size
      • 7.1.11.3 South America Online Pharmacies Market Size
      • 7.1.11.4 South America Veterinary Pharmacies Market Size
      • 7.1.11.5 South America Veterinary Hospitals & Clinics Market Size
    • 7.1.12 South America Anthelmintic Drugs Volume Market Sales by Distribution Channel 2022 - 2034
      • 7.1.12.1 South America Hospital Pharmacies Sales Volume
      • 7.1.12.2 South America Retail Pharmacies Sales Volume
      • 7.1.12.3 South America Online Pharmacies Sales Volume
      • 7.1.12.4 South America Veterinary Pharmacies Sales Volume
      • 7.1.12.5 South America Veterinary Hospitals & Clinics Sales Volume

  • 8.1 Middle East Anthelmintic Drugs Market Outlook
    • 8.1.1 Middle East Anthelmintic Drugs Market Size 2022 - 2034
    • 8.1.2 Middle East Anthelmintic Drugs Volume Market Sales 2022 - 2034
    • 8.1.3 Middle East Anthelmintic Drugs Market Size By Country 2022 - 2034
    • 8.1.4 Middle East Anthelmintic Drugs Volume Market Sales By Country 2022 - 2034
    • 8.1.5 Middle East Anthelmintic Drugs Market Size by Drug Class 2022 - 2034
      • 8.1.5.1 Middle East Benzimidazoles Market Size
      • 8.1.5.2 Middle East Piperazine Market Size
      • 8.1.5.3 Middle East Others Market Size
    • 8.1.6 Middle East Anthelmintic Drugs Volume Market Sales by Drug Class 2022 - 2034
      • 8.1.6.1 Middle East Benzimidazoles Sales Volume
      • 8.1.6.2 Middle East Piperazine Sales Volume
      • 8.1.6.3 Middle East Others Sales Volume
    • 8.1.7 Middle East Anthelmintic Drugs Market Size by Application 2022 - 2034
      • 8.1.7.1 Middle East Human Market Size
      • 8.1.7.2 Middle East Animal Market Size
    • 8.1.8 Middle East Anthelmintic Drugs Volume Market Sales by Application 2022 - 2034
      • 8.1.8.1 Middle East Human Sales Volume
      • 8.1.8.2 Middle East Animal Sales Volume
    • 8.1.9 Middle East Anthelmintic Drugs Market Size by Route of Administration 2022 - 2034
      • 8.1.9.1 Middle East Oral Market Size
      • 8.1.9.2 Middle East Injectable Market Size
    • 8.1.10 Middle East Anthelmintic Drugs Volume Market Sales by Route of Administration 2022 - 2034
      • 8.1.10.1 Middle East Oral Sales Volume
      • 8.1.10.2 Middle East Injectable Sales Volume
    • 8.1.11 Middle East Anthelmintic Drugs Market Size by Distribution Channel 2022 - 2034
      • 8.1.11.1 Middle East Hospital Pharmacies Market Size
      • 8.1.11.2 Middle East Retail Pharmacies Market Size
      • 8.1.11.3 Middle East Online Pharmacies Market Size
      • 8.1.11.4 Middle East Veterinary Pharmacies Market Size
      • 8.1.11.5 Middle East Veterinary Hospitals & Clinics Market Size
    • 8.1.12 Middle East Anthelmintic Drugs Volume Market Sales by Distribution Channel 2022 - 2034
      • 8.1.12.1 Middle East Hospital Pharmacies Sales Volume
      • 8.1.12.2 Middle East Retail Pharmacies Sales Volume
      • 8.1.12.3 Middle East Online Pharmacies Sales Volume
      • 8.1.12.4 Middle East Veterinary Pharmacies Sales Volume
      • 8.1.12.5 Middle East Veterinary Hospitals & Clinics Sales Volume

  • 9.1 Africa Anthelmintic Drugs Market Outlook
    • 9.1.1 Africa Anthelmintic Drugs Market Size 2022 - 2034
    • 9.1.2 Africa Anthelmintic Drugs Volume Market Sales 2022 - 2034
    • 9.1.3 Africa Anthelmintic Drugs Market Size By Country 2022 - 2034
    • 9.1.4 Africa Anthelmintic Drugs Volume Market Sales By Country 2022 - 2034
    • 9.1.5 Africa Anthelmintic Drugs Market Size by Drug Class 2022 - 2034
      • 9.1.5.1 Africa Benzimidazoles Market Size
      • 9.1.5.2 Africa Piperazine Market Size
      • 9.1.5.3 Africa Others Market Size
    • 9.1.6 Africa Anthelmintic Drugs Volume Market Sales by Drug Class 2022 - 2034
      • 9.1.6.1 Africa Benzimidazoles Sales Volume
      • 9.1.6.2 Africa Piperazine Sales Volume
      • 9.1.6.3 Africa Others Sales Volume
    • 9.1.7 Africa Anthelmintic Drugs Market Size by Application 2022 - 2034
      • 9.1.7.1 Africa Human Market Size
      • 9.1.7.2 Africa Animal Market Size
    • 9.1.8 Africa Anthelmintic Drugs Volume Market Sales by Application 2022 - 2034
      • 9.1.8.1 Africa Human Sales Volume
      • 9.1.8.2 Africa Animal Sales Volume
    • 9.1.9 Africa Anthelmintic Drugs Market Size by Route of Administration 2022 - 2034
      • 9.1.9.1 Africa Oral Market Size
      • 9.1.9.2 Africa Injectable Market Size
    • 9.1.10 Africa Anthelmintic Drugs Volume Market Sales by Route of Administration 2022 - 2034
      • 9.1.10.1 Africa Oral Sales Volume
      • 9.1.10.2 Africa Injectable Sales Volume
    • 9.1.11 Africa Anthelmintic Drugs Market Size by Distribution Channel 2022 - 2034
      • 9.1.11.1 Africa Hospital Pharmacies Market Size
      • 9.1.11.2 Africa Retail Pharmacies Market Size
      • 9.1.11.3 Africa Online Pharmacies Market Size
      • 9.1.11.4 Africa Veterinary Pharmacies Market Size
      • 9.1.11.5 Africa Veterinary Hospitals & Clinics Market Size
    • 9.1.12 Africa Anthelmintic Drugs Volume Market Sales by Distribution Channel 2022 - 2034
      • 9.1.12.1 Africa Hospital Pharmacies Sales Volume
      • 9.1.12.2 Africa Retail Pharmacies Sales Volume
      • 9.1.12.3 Africa Online Pharmacies Sales Volume
      • 9.1.12.4 Africa Veterinary Pharmacies Sales Volume
      • 9.1.12.5 Africa Veterinary Hospitals & Clinics Sales Volume

  • 10.1 Top Competitors Analysis

    • (Subject to Data Availability (Private Players))

      10.1.1 Global Anthelmintic Drugs Market Revenue and Share by Key Players
    • 10.1.2 Global Anthelmintic Drugs Market Volume and Share by Key Players
    • 10.1.3 Top Players Ranking 2024
    • 10.1.4 New Product Launch Analysis
    • 10.1.5 Industry Mergers and Acquisition Analysis
  • 10.2 Company Profile (Data Subject to Availability) Sample Format

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      10.2.1 GlaxoSmithKline plc 
      • 10.2.1.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 10.2.1.2 Business Overview
      • 10.2.1.3 Financials (Subject to data availability)
      • 10.2.1.4 R&D Investment (Subject to data availability)
      • 10.2.1.5 Product Types Specification
      • 10.2.1.6 Business Strategy
      • 10.2.1.7 Recent Developments
      • 10.2.1.8 Management Change
      • 10.2.1.9 S.W.O.T Analysis

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      10.2.2 Johnson & Johnson 
      • 10.2.2.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 10.2.2.2 Business Overview
      • 10.2.2.3 Financials (Subject to data availability)
      • 10.2.2.4 R&D Investment (Subject to data availability)
      • 10.2.2.5 Product Types Specification
      • 10.2.2.6 Business Strategy
      • 10.2.2.7 Recent Developments
      • 10.2.2.8 Management Change
      • 10.2.2.9 S.W.O.T Analysis

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      10.2.3 Merck & Co. Inc. 
      • 10.2.3.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 10.2.3.2 Business Overview
      • 10.2.3.3 Financials (Subject to data availability)
      • 10.2.3.4 R&D Investment (Subject to data availability)
      • 10.2.3.5 Product Types Specification
      • 10.2.3.6 Business Strategy
      • 10.2.3.7 Recent Developments
      • 10.2.3.8 Management Change
      • 10.2.3.9 S.W.O.T Analysis

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      10.2.4 Bayer AG 
      • 10.2.4.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 10.2.4.2 Business Overview
      • 10.2.4.3 Financials (Subject to data availability)
      • 10.2.4.4 R&D Investment (Subject to data availability)
      • 10.2.4.5 Product Types Specification
      • 10.2.4.6 Business Strategy
      • 10.2.4.7 Recent Developments
      • 10.2.4.8 Management Change
      • 10.2.4.9 S.W.O.T Analysis

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      10.2.5 Cipla Ltd. 
      • 10.2.5.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 10.2.5.2 Business Overview
      • 10.2.5.3 Financials (Subject to data availability)
      • 10.2.5.4 R&D Investment (Subject to data availability)
      • 10.2.5.5 Product Types Specification
      • 10.2.5.6 Business Strategy
      • 10.2.5.7 Recent Developments
      • 10.2.5.8 Management Change
      • 10.2.5.9 S.W.O.T Analysis

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      10.2.6 Sun Pharmaceutical Industries Ltd. 
      • 10.2.6.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 10.2.6.2 Business Overview
      • 10.2.6.3 Financials (Subject to data availability)
      • 10.2.6.4 R&D Investment (Subject to data availability)
      • 10.2.6.5 Product Types Specification
      • 10.2.6.6 Business Strategy
      • 10.2.6.7 Recent Developments
      • 10.2.6.8 Management Change
      • 10.2.6.9 S.W.O.T Analysis

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      10.2.7 Teva Pharmaceutical Industries Limited 
      • 10.2.7.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 10.2.7.2 Business Overview
      • 10.2.7.3 Financials (Subject to data availability)
      • 10.2.7.4 R&D Investment (Subject to data availability)
      • 10.2.7.5 Product Types Specification
      • 10.2.7.6 Business Strategy
      • 10.2.7.7 Recent Developments
      • 10.2.7.8 Management Change
      • 10.2.7.9 S.W.O.T Analysis

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      10.2.8 Reese Pharmaceutical Company 
      • 10.2.8.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 10.2.8.2 Business Overview
      • 10.2.8.3 Financials (Subject to data availability)
      • 10.2.8.4 R&D Investment (Subject to data availability)
      • 10.2.8.5 Product Types Specification
      • 10.2.8.6 Business Strategy
      • 10.2.8.7 Recent Developments
      • 10.2.8.8 Management Change
      • 10.2.8.9 S.W.O.T Analysis

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      10.2.9 Zydus Lifesciences Limited
      • 10.2.9.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 10.2.9.2 Business Overview
      • 10.2.9.3 Financials (Subject to data availability)
      • 10.2.9.4 R&D Investment (Subject to data availability)
      • 10.2.9.5 Product Types Specification
      • 10.2.9.6 Business Strategy
      • 10.2.9.7 Recent Developments
      • 10.2.9.8 Management Change
      • 10.2.9.9 S.W.O.T Analysis

  • 11.1 Market Drivers
  • 11.2 Market Restraints
  • 11.3 Market Trends
  • 11.4 Market Opportunity
  • 11.5 Technological Road Map (Subject to Data Availability)
  • 11.6 Product Life Cycle (Subject to Data Availability)
  • 11.7 Customer and Buyer Behavior Analysis
    • 11.7.1 Consumer Demographics and Target Audience Assessment
    • 11.7.2 Consumer Purchase Behavior and Demand Assessment
    • 11.7.3 Consumer Pricing Dynamics and Affordability Assessment
    • 11.7.4 Digital Consumer Engagement and Online Adoption Analysis
    • 11.7.5 Future Consumption Trends and Demand Evolution Analysis
    • 11.7.6 Enterprise Procurement & Purchasing Behavior Analysis
    • 11.7.7 Buyer Decision-Making & Purchase Influence Assessment
    • 11.7.8 Customer Expectations & Service Experience Evaluation
    • 11.7.9 Vendor Selection & Supplier Preference Analysis
    • 11.7.10 Customer Retention & Loyalty Strategy Assessment
    • 11.7.11 Pricing Sensitivity & Value Perception Analysis
    • 11.7.12 Customer Segmentation & Demand Pattern Analysis
    • 11.7.13 Relationship Management & Strategic Partnership Trends
  • 11.8 Market Attractiveness Analysis
  • 11.9 PESTEL Analysis
    • 11.9.1 Political Factors
    • 11.9.2 Economic Factors
    • 11.9.3 Social Factors
    • 11.9.4 Technological Factors
    • 11.9.5 Legal Factors
    • 11.9.6 Environmental Factors
  • 11.10 Industrial Chain Analysis (Subject to Data Availability)
    • 11.10.1 Industry Chain Analysis
    • 11.10.2 Manufacturing Cost Analysis
    • 11.10.3 Supply Side Analysis
      • 11.10.3.1 Raw Material Analysis
      • 11.10.3.2 Raw Material Procurement Analysis
      • 11.10.3.3 Raw Material Price Trend Analysis
  • 11.11 Porter’s Five Forces Analysis
    • 11.11.1 Bargaining Power of Suppliers
    • 11.11.2 Bargaining Power of Buyers
    • 11.11.3 Threat of New Entrants
    • 11.11.4 Threat of Substitutes
    • 11.11.5 Degree of Competition
  • 11.12 Patent Analysis (Subject to Data Availability)
  • 11.13 ESG Analysis

  • 12.1 Benzimidazoles
    • 12.1.1 Global Anthelmintic Drugs Revenue Market Size and Share by Benzimidazoles 2022 - 2034
    • 12.1.2 Global Anthelmintic Drugs Volume Market Sales by Benzimidazoles 2022 - 2034
  • 12.2 Piperazine
    • 12.2.1 Global Anthelmintic Drugs Revenue Market Size and Share by Piperazine 2022 - 2034
    • 12.2.2 Global Anthelmintic Drugs Volume Market Sales by Piperazine 2022 - 2034
  • 12.3 Others
    • 12.3.1 Global Anthelmintic Drugs Revenue Market Size and Share by Others 2022 - 2034
    • 12.3.2 Global Anthelmintic Drugs Volume Market Sales by Others 2022 - 2034

  • 13.1 Human
    • 13.1.1 Global Anthelmintic Drugs Revenue Market Size and Share by Human 2022 - 2034
    • 13.1.2 Global Anthelmintic Drugs Volume Market Sales by Human 2022 - 2034
  • 13.2 Animal
    • 13.2.1 Global Anthelmintic Drugs Revenue Market Size and Share by Animal 2022 - 2034
    • 13.2.2 Global Anthelmintic Drugs Volume Market Sales by Animal 2022 - 2034

  • 14.1 Oral
    • 14.1.1 Global Anthelmintic Drugs Revenue Market Size and Share by Oral 2022 - 2034
    • 14.1.2 Global Anthelmintic Drugs Volume Market Sales by Oral 2022 - 2034
  • 14.2 Injectable
    • 14.2.1 Global Anthelmintic Drugs Revenue Market Size and Share by Injectable 2022 - 2034
    • 14.2.2 Global Anthelmintic Drugs Volume Market Sales by Injectable 2022 - 2034

  • 15.1 Hospital Pharmacies
    • 15.1.1 Global Anthelmintic Drugs Revenue Market Size and Share by Hospital Pharmacies 2022 - 2034
    • 15.1.2 Global Anthelmintic Drugs Volume Market Sales by Hospital Pharmacies 2022 - 2034
  • 15.2 Retail Pharmacies
    • 15.2.1 Global Anthelmintic Drugs Revenue Market Size and Share by Retail Pharmacies 2022 - 2034
    • 15.2.2 Global Anthelmintic Drugs Volume Market Sales by Retail Pharmacies 2022 - 2034
  • 15.3 Online Pharmacies
    • 15.3.1 Global Anthelmintic Drugs Revenue Market Size and Share by Online Pharmacies 2022 - 2034
    • 15.3.2 Global Anthelmintic Drugs Volume Market Sales by Online Pharmacies 2022 - 2034
  • 15.4 Veterinary Pharmacies
    • 15.4.1 Global Anthelmintic Drugs Revenue Market Size and Share by Veterinary Pharmacies 2022 - 2034
    • 15.4.2 Global Anthelmintic Drugs Volume Market Sales by Veterinary Pharmacies 2022 - 2034
  • 15.5 Veterinary Hospitals & Clinics
    • 15.5.1 Global Anthelmintic Drugs Revenue Market Size and Share by Veterinary Hospitals & Clinics 2022 - 2034
    • 15.5.2 Global Anthelmintic Drugs Volume Market Sales by Veterinary Hospitals & Clinics 2022 - 2034

  • 16.1 Company Gap Assessment Analysis
  • 16.2 Product & Service Portfolio Gap Analysis
  • 16.3 Demand-Supply Imbalance Analysis
  • 16.4 Market Opportunity & Unmet Needs Analysis
  • 16.5 Technology Adoption & Digital Transformation Gap Analysis
  • 16.6 Operational Efficiency & Process Gap Analysis
  • 16.7 Infrastructure & Capacity Gap Analysis
  • 16.8 Geographic Coverage & Distribution Gap Analysis
  • 16.9 Investment Opportunity & Funding Gap Analysis
  • 16.10 Pricing Structure & Margin Gap Analysis
  • 16.11 Innovation & R&D Capability Gap Analysis
  • 16.12 Policy, Compliance & Regulatory Gap Analysis
  • 16.13 Customer Experience & Expectation Gap Analysis
  • 16.14 Future Growth Opportunity Gap Analysis
  • 16.15 Market Accessibility & Penetration Gap Analysis

  • 17.1 Gross Margin Overview and Industry Profitability Trends
  • 17.2 Regional Gross Margin Performance Analysis
  • 17.3 Supply Chain and Distribution Impact on Gross Margins
  • 17.4 Pricing Strategy and Value-Added Margin Assessment
  • 17.5 Key Factors Influencing Gross Margin Variability
  • 17.6 Future Gross Margin Outlook and Profitability Trends

  • 18.1 Key Takeaways

  • Here the analyst will summarize the content of entire report and will share his view point on the current industry scenario and how the market is expected to perform in the near future. The points shared by the analyst are based on his/her detailed in-depth understanding of the market during the course of this report study. You will be provided exclusive rights to interact with the concerned analyst for unlimited time pre purchase as well as post purchase of the report.

    18.2 Analyst Point of View
  • 18.3 Assumptions and Acronyms

  • 19.1 Primary Data Collection
    • 19.1.1 Steps for Primary Data Collection
      • 19.1.1.1 Identification of KOL
    • 19.1.2 Backward Integration
    • 19.1.3 Forward Integration
    • 19.1.4 How Primary Research Help Us
    • 19.1.5 Modes of Primary Research
  • 19.2 Secondary Research
    • 19.2.1 How Secondary Research Help Us
    • 19.2.2 Sources of Secondary Research
  • 19.3 Data Validation
    • 19.3.1 Data Triangulation
    • 19.3.2 Top Down & Bottom Up Approach
    • 19.3.3 Cross check KOL Responses with Secondary Data
  • 19.4 Data Representation

Athenaeum AI Dashboard

Research Framework · 70:30 Primary:Secondary

Our Proprietary Methodology

Cognitive Market Research employs "The Full Truth™" methodology — a rigorous triangulation process that combines primary research, secondary validation, and expert calibration. Implemented by Supriya Yadav and team for the Anthelmintic Drugs Market Analysis Market analysis.

01

Primary Intelligence Gathering

Direct interviews with 50+ industry stakeholders including manufacturers, distributors, end-users, and regulatory bodies across all six regions.

02

Secondary Data Triangulation

Cross-referencing against trade databases, customs records, financial filings, patent databases, and verified industry publications.

03

Expert Validation Protocol

Each data point undergoes validation by minimum two independent domain experts with 15+ years of industry experience.

04

Athenaeum AI Processing

Our proprietary AI platform aggregates, normalizes, and identifies patterns across 10,000+ data points to surface non-obvious insights.

05

Editorial & QA Review

Final review by senior analysts ensures accuracy, coherence, and actionability of all insights and recommendations.

Data Assurance Metrics
Data Points Validated 10,400+
Expert Interviews 54
Countries Covered 39+
Company Profiles 9+
Forecast Accuracy (Historical) 94.2%
Report Pages 250+
Analytical Coverage
Market Sizing Revenue Forecast CAGR Analysis Competitor Benchmarking SWOT Porter's Analysis PESTEL Value Chain ESG Analysis Tariff Impact Patent Mapping Tech Trends

To maintain the integrity of our proprietary methodology and protect our elite expert network, specific source disclosures are reserved for full-access partners. Our research framework is anchored by a 70:30 primary-to-secondary ratio, ensuring your strategy is driven by real-time market intelligence rather than recycled, publicly available, or AI-generated data. Every deliverable includes an exhaustive source directory and grants direct analyst access.

Latest News about Anthelmintic Drugs Market

Sources from Pharma & Healthcare Industry

How We Serve You

Three Pillars of Market Intelligence

We don't just hand over data. We partner with your team across three integrated service lines — each designed to give you decision-grade intelligence on the Anthelmintic Drugs Market Analysis market.

Service 01

Market Survey

B2B B2C

Structured primary research across both B2B and B2C channels. We design and execute custom surveys targeting manufacturers, distributors, procurement heads, and end-consumers in the anthelmintic drugs market analysis ecosystem — validated by our global panel of 10,000+ industrial respondents.

What's Included
  • Buyer intent & sentiment analysis
  • Purchase cycle mapping
  • Price sensitivity research
  • Channel preference profiling
  • Competitive perception study
Most Requested
Service 02

Customized Market Data & Reports

Custom Ready Report

Choose from our ready-to-access 8th Edition report or commission a fully customized dataset tailored to your exact strategic questions. Cross-splits, custom geographies, proprietary segmentation — we build the intelligence asset your board actually needs.

What's Included
  • Ready syndicate report (250+ pages)
  • Custom data scope & segmentation
  • Excel quantitative models
  • Board-ready PPT with key findings
  • Secure cloud portal access
Service 03

Strategic Consultation

With Survey With Report

Every survey and every report comes with dedicated analyst consultation. Our senior research team walks your leadership through findings, answers strategic questions in real-time, and helps translate data into your next board presentation or investment thesis.

What's Included
  • Dedicated analyst assigned to you
  • Live walkthrough of findings
  • Strategic Q&A sessions
  • Go-to-market recommendations
  • NDA-protected engagement

Customize This Report

Tell us the specific segments, regions, or companies you need — and we will tailor the deliverable to your requirements.